Active Biotech AB (ACTI) — Financial Flexibility Index
Active Biotech AB (ACTI) has a Financial Flexibility Index of -0.58x as of September 2025. Free cash flow of Skr-7.20 Million (operating CF Skr-7.20 Million minus capex Skr0.00) represents -1% of total liabilities (Skr12.50 Million). Also explore Active Biotech AB equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Active Biotech AB Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Active Biotech AB across 23 annual periods. Check Active Biotech AB (ACTI) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Active Biotech AB (2002–2024)
Year-by-year free cash flow to debt coverage for Active Biotech AB. For the full company profile including market capitalisation, see ACTI market cap.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.63x | Skr-40.40 Million | Skr-40.40 Million | Skr11.13 Million | ▼ -6.2% |
| 2023 | -3.42x | Skr-45.74 Million | Skr-45.74 Million | Skr13.38 Million | ▼ -3.3% |
| 2022 | -3.31x | Skr-54.60 Million | Skr-54.85 Million | Skr16.49 Million | ▲ +27.4% |
| 2021 | -4.56x | Skr-46.17 Million | Skr-46.17 Million | Skr10.13 Million | ▼ -42.1% |
| 2020 | -3.21x | Skr-32.22 Million | Skr-32.22 Million | Skr10.04 Million | ▼ -18.0% |
| 2019 | -2.72x | Skr-35.81 Million | Skr-35.81 Million | Skr13.17 Million | ▼ -1335.0% |
| 2018 | -0.19x | Skr-40.65 Million | Skr-40.65 Million | Skr214.52 Million | ▲ +7.7% |
| 2017 | -0.21x | Skr-46.45 Million | Skr-46.45 Million | Skr226.14 Million | ▲ +35.3% |
| 2016 | -0.32x | Skr-73.16 Million | Skr-73.16 Million | Skr230.32 Million | ▲ +60.8% |
| 2015 | -0.81x | Skr-217.89 Million | Skr-217.89 Million | Skr268.84 Million | ▲ +3.1% |
| 2014 | -0.84x | Skr-265.19 Million | Skr-267.09 Million | Skr317.21 Million | ▼ -196.4% |
| 2013 | -0.28x | Skr-102.20 Million | Skr-102.25 Million | Skr362.40 Million | ▲ +58.1% |
| 2012 | -0.67x | Skr-240.38 Million | Skr-240.40 Million | Skr356.82 Million | ▼ -417.1% |
| 2011 | -0.13x | Skr-46.44 Million | Skr-46.97 Million | Skr356.53 Million | ▲ +78.7% |
| 2010 | -0.61x | Skr-196.23 Million | Skr-196.32 Million | Skr321.34 Million | ▲ +15.8% |
| 2009 | -0.73x | Skr-224.70 Million | Skr-224.77 Million | Skr309.86 Million | ▼ -43.2% |
| 2008 | -0.51x | Skr-156.61 Million | Skr-159.46 Million | Skr309.34 Million | ▲ +18.6% |
| 2007 | -0.62x | Skr-186.61 Million | Skr-186.70 Million | Skr299.97 Million | ▼ -149.9% |
| 2006 | -0.25x | Skr-100.10 Million | Skr-100.13 Million | Skr402.04 Million | ▲ +48.0% |
| 2005 | -0.48x | Skr-187.28 Million | Skr-192.51 Million | Skr391.05 Million | ▲ +51.8% |
| 2004 | -0.99x | Skr-149.58 Million | Skr-149.65 Million | Skr150.59 Million | ▲ +80.8% |
| 2003 | -5.17x | Skr-288.76 Million | Skr-288.83 Million | Skr55.82 Million | ▼ -54.9% |
| 2002 | -3.34x | Skr-291.31 Million | Skr-291.71 Million | Skr87.24 Million | — |